Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
4,404,649
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1,834,857
-
Shares change
-
+1,834,524
-
Total reported value, excl. options
-
$20,524,000
-
Value change
-
+$20,521,000
-
Number of buys
-
18
-
Price
-
$11.18
Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q2 2021
As of 30 Jun 2021 Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,834,857 shares of stock of the company.
Largest 10 holders included FMR LLC, Rock Springs Capital Management LP, Foresite Capital Management IV, LLC, FIL Ltd, NEA Management Company, LLC, Monashee Investment Management LLC, Maven Securities LTD, Ikarian Capital, LLC, VANGUARD GROUP INC, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 19 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.